Hire an Advanced Robo-Advisor to Trade AGN on Your Behalf.
- Street Sentiment
- Personalized Strategy
- Free Trading Simulator
Course of Action
Sentiment (10 days)
- Strong Buy
- Strong Sell
DAILY PRICE CHANGE VS SENTIMENT
Why Use a Robo-Advisor to invest?
Smart Auto-Trading is an advanced robo-advisor designed to provides investors with a trading partner to automate systematic investing. Its robo is designed to screens, monitors and auto-trades elite stocks like ALLERGAN, INC. (AGN) using artificial intelligence, social media and market data to augments your potential as an investor.
Smart Auto-Trading produces short-term trades which makes it an ideal tool for trading in tax-deferred accounts such as IRA, SIMPLE IRA, Rollover IRA, 529 College Plans, Keoghs and UGMA. It also works in taxable accounts. Just be aware that if you elect to auto-trade using Smart Auto-Trading in a regular brokerage account, you will be taxed at regular income. Make sure you understand your tax situation before using Smart Auto-trading.
Using Smart Auto-Trading is easy. It connects to your brokerage account at Ally Invest, one of the most trusted broker/dealer in the United States. All you need to do is open an account with them, put a minimum of $5,000 in your account and connect Smart Auto-Trading to trade.
There are clear benefits associated with using a robo-advisor such as Smart Auto-Trading to help you reach your financial goals. Smart Auto-Trading simplifies stock investing down to a few steps. It auto-trades for you, using your personalized strategy, while you attend more important life events.
'Trading on the news' is a technique used by traders to justify buying or selling securities. News reports often spur short-term moves in the market, creating trading opportunities.
Announcements about earnings, product launches, changes in management, all are events that can cause a company's stock price to move up or down.
Digital news sources
Today, news travels through digital means. It reaches social networks at breakneck speed. News can spread virally from the originator to millions of people in a matter of minutes. If the news has material value, it is re-tweeted immediately.
News sentiment analysis
Smart Auto-Trading sift through 1000s of news elements in seconds, figure out the subject, how many people are talking about it and if the news is positive or negative.
With this technology, gone are the days of staring at a Bloomberg terminal for the purpose of identifying trading opportunities. Computers essentially have mastered how to 'trade on the news'. This technology is virtually eliminating the need to pay someone to watch over your portfolio.
Sentiment based Wall Street
As of 2009, Wikipedia states that computers who are using events to trigger trades, accounted for 60% of all US stock market trading volume.' In 2017, this phenomenon has ballooned to 75% of all equity trades.
Wall Street's automated strategies have become so pervasive that we can say that the market is about to become fully robotized.
Automated 'trading on the news' brings about a new world of opportunities, where investors will get a better 'bang for their buck' without the need for a traditional Investment Advisor. All they will really need is a brokerage account and access to their favorite auto-trading tool.
Using Smart Auto-Trading is like having thousands of traders working for you to help you reach your financial goals.
Smart Auto-Trading actively trades which is different from passive investing. The robo is on the lookout working to maximize your potential every business day of the year. It trades on the news taking advantage of price changes and trends by listening into trader's communications and by validating this information with market data.
Smart Auto-Trading is one of the first robo-advisor to take advantage of Government grade listening technology, artificial intelligence, social media and market data natively.
Try Smart Auto-Trading today!
You can test Smart Auto-Trading in simulation mode, risk free, Stock Circles today.
Disclaimer: Past performance may not be indicative of future results. Therefore, you should assume that the future performance of any specific investment, investment strategy (including robo-strategies), or product made in reference directly or indirectly on this website, will be profitable or equal to corresponding indicated performance levels. Robot-Advisors like other investment methods rely on favorable market conditions to provide positive outcomes.
ALLERGAN, INC. (AGN) News
William Blair Investment Management LLC Has $28.69 Million Position in Allergan PLC. (AGN)
William Blair Investment Management LLC trimmed its position in Allergan PLC. (NYSE:AGN) by 1.5% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 118,027 shares of the company’s stock after selling 1,757 shares during the period. William Blair Investment Management LLC’s holdings in Allergan PLC. were worth $28,691,000 at the end of the most recent reporting period.
Several other institutional investors also recently modified their holdings of the company. Veritas Asset Management LLP purchased a new stake in shares of Allergan PLC. during the 1st quarter valued at approximately $761,339,000. Edgewood Management LLC raised its position in shares of Allergan PLC. by 7.0% during the 1st quarter. Edgewood Management LLC now owns 2,704,211 shares of the company’s stock valued at $646,090,000 after buying an additional 178,055 shares during the period. Epoch Investment Partners Inc. raised its position in shares of Allergan PLC. by 3.8% during the 1st quarter. Epoch Investment Partners Inc. now owns 2,013,415 shares of the company’s stock valued at $481,045,000 after buying an additional 73,081 shares during the period. UBS Asset Management Americas Inc. raised its position in shares of Allergan PLC. by 0.3% during the 1st quarter. UBS Asset Management Americas Inc. now owns 1,995,281 shares of the company’s stock valued at $476,713,000 after buying an additional 5,042 shares during the period. Finally, Blue Ridge Capital L.L.C. raised its position in Allergan PLC. by 24.1% in the first quarter. Blue Ridge Capital L.L.C. now owns 1,909,900 shares of the company’s stock valued at $456,313,000 after purchasing an additional 370,400 shares during the period. Institutional investors and hedge funds own 82.02% of the company’s stock.
Several research firms have commented on AGN. Deutsche Bank AG restated a “buy” rating and issued a $262.00 price target on shares of Allergan PLC. in a research note on Tuesday, September 12th. Wells Fargo & Company reiterated an “outperform” rating on shares of Allergan PLC. in a research note on Monday, September 11th. Royal Bank Of Canada restated a “buy” rating and issued a $285.00 price objective on shares of Allergan PLC. in a research note on Wednesday, September 6th. Cantor Fitzgerald restated a “hold” rating on shares of Allergan PLC. in a research note on Tuesday, August 29th. Finally, Cowen and Company restated an “outperform” rating and issued a $400.00 price objective on shares of Allergan PLC. in a research note on Tuesday, August 29th. One analyst has rated the stock with a sell rating, seven have issued a hold rating and fifteen have issued a buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $274.69.
Allergan PLC. (AGN) opened at 220.29 on Monday. The stock has a market cap of $73.64 billion, a P/E ratio of 6.71 and a beta of 1.18. Allergan PLC. has a 1-year low of $184.50 and a 1-year high of $256.80. The firm’s 50-day moving average is $231.75 and its 200-day moving average is $236.59.
Allergan PLC. (NYSE:AGN) last released its earnings results on Thursday, August 3rd. The company reported $4.02 earnings per share for the quarter, beating the consensus estimate of $3.95 by $0.07. Allergan PLC. had a net margin of 79.17% and a return on equity of 7.37%. The business had revenue of $4.01 billion during the quarter, compared to analysts’ expectations of $3.95 billion. During the same period last year, the business earned $3.35 earnings per share. The firm’s revenue was up 8.8% on a year-over-year basis. On average, analysts forecast that Allergan PLC. will post $16.25 EPS for the current year.
The business also recently disclosed a quarterly dividend, which was paid on Friday, September 15th. Shareholders of record on Friday, August 18th were given a dividend of $0.70 per share. The ex-dividend date of this dividend was Wednesday, August 16th. This represents a $2.80 dividend on an annualized basis and a yield of 1.27%. Allergan PLC.’s dividend payout ratio (DPR) is 9.95%.Get Started today! - Risk Free